Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04735874 Completed - Atherosclerosis Clinical Trials

Vascular Health and Risk Factors in Children With Down Syndrome

Start date: February 2, 2021
Phase:
Study type: Observational

This is a prospective, multicenter, cross-sectional study to evaluate prevalence of vascular risk factors in children with Down Syndrome and to determine the association between vascular disease risk factors and objective markers of early atherosclerosis.

NCT ID: NCT04734990 Recruiting - Clinical trials for Myelodysplastic Syndrome

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Start date: July 7, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial identifies the best dose of seclidemstat when given together with azacitidine in treating patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Seclidemstat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Azacitidine may help block the formation of growths that may become cancer. Giving seclidemstat and azacytidine may kill more cancer cells.

NCT ID: NCT04734847 Recruiting - Clinical trials for Interstitial Cystitis

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

IcBrainStim
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor muscle activity. However, prior studies have examined rTMS in a very limited sample and have not examined changes in brain or pelvic floor muscle activity to determine the mechanism of rTMS for IC/BPS. This study is designed to directly address these limitations.

NCT ID: NCT04734613 Completed - Metabolic Syndrome Clinical Trials

Tai Chi for Behavioral Modification Among Individuals With Metabolic Syndrome

Start date: December 10, 2020
Phase: N/A
Study type: Interventional

This is the randomized trial to explore the effect of behavioral modification program (Tai Chi vs. self management) on adults with metabolic syndrome. The outcome variables include health behavior, metabolic syndrome indicators, quality of life.

NCT ID: NCT04734379 Active, not recruiting - Clinical trials for Progressive Supranuclear Palsy

Rho Kinase (ROCK) Inhibitor in Tauopathies - 1

ROCKIT-1
Start date: January 22, 2021
Phase: Phase 2
Study type: Interventional

A Phase 2a Open-Label Preliminary Safety, Tolerability, and Biomarker Study of Oral Fasudil in Patients with the 4-Repeat Tauopathies of Progressive Supranuclear Palsy-Richardson Syndrome or Corticobasal Syndrome

NCT ID: NCT04734041 Completed - Clinical trials for Ehlers-Danlos Syndrome

Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)

Start date: December 23, 2020
Phase: N/A
Study type: Interventional

A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)

NCT ID: NCT04733066 Recruiting - Clinical trials for Short Bowel Syndrome

Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis

MatchedQoL
Start date: September 1, 2020
Phase:
Study type: Observational

The aim of this prospective longitudinal study is to compare the quality of life of short bowel patients prior to and on teduglutide treatment with a non-treated patient group in a matched-pair design.

NCT ID: NCT04732338 Completed - Headache Clinical Trials

The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome

Start date: August 1, 2017
Phase: Early Phase 1
Study type: Interventional

Pilot study looking at the Osteopathic Manipulative Treatment (OMT) for various headache types in patients with post-concussion syndrome (PCS). Twenty-six subjects with symptoms lasting >3 months were enrolled and were randomly assigned to a treatment group (n = 13) and a control group (n = 13).

NCT ID: NCT04732325 Recruiting - Chronic Pain Clinical Trials

Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain

Start date: September 11, 2021
Phase: N/A
Study type: Interventional

Doctors sometimes treat chronic pain with devices that send mild electrical currents into the spinal cord. This type of treatment is referred to as neurostimulation. A common form of neurostimulation therapy is spinal cord stimulation (SCS). In this study, researchers want to learn more about how SCS affects pain processing and relieves pain. The researchers will examine multiple forms of SCS in chronic pain patients who are receiving SCS from their own doctors as part of their standard of care. During the study, participants will be asked to complete a variety of evaluations at certain time points.

NCT ID: NCT04731493 Active, not recruiting - Marfan Syndrome Clinical Trials

Effect on the Quality of Life of a Therapeutic Education Program in Patients With Marfan Syndrome

MYLIFE
Start date: December 2, 2020
Phase:
Study type: Observational

This is a before-after, observational, prospective, multicenter cohort study. The study will consist of 2 phases: an initial observational phase of a minimum of 3 months before the Therapeutic Education Program (TEP) intervention, then a phase of evolution analysis of at least 3 months.